Table 4 Clusters within the YGL capsule-HB network
From: Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment
Cluster | Score | Nodes | Edges | Node |
|---|---|---|---|---|
1 | 4.833 | 13 | 29 | AIRE, PSMB9, HCK, PSMA7, PSMB5, PSMA3, PSMB8, AR, PLCG1, MET, FASLG, SRC, PSMD1 |
2 | 3.5 | 9 | 14 | CHUK, SOCS3, STAT3, GRB2, CXCR4, NFKBIA, TNFRSF1A, JAK1, PTPRC |
3 | 3.5 | 9 | 14 | GFAP, BECN1, VIM, EIF2AK2, PML, HMGB1, IFI16, CDK1, STAT1 |
4 | 3.333 | 4 | 5 | TNFAIP3, IKBKG, FYN, TNF |
5 | 3.2 | 6 | 8 | KRT8, EGFR, KRT18, PIK3R1, SOCS1, IFNAR1 |
6 | 3.2 | 6 | 8 | CD81, ICAM1, HNRNPA1, SRPK1, SRPK2, HIST1H1E |
7 | 3 | 9 | 12 | KRT19, GSTP1, NFKB1, ESR1, FN1, CUL5, ISG15, HNRNPK,TP53 |
8 | 3 | 5 | 6 | GLTSCR2, C1QBP, NPM1, YWHAE, PUM3 |